MSD Ukraine
Multinational biopharmaceutical company engaged in discovery, development and delivery of medicines and vaccines. The Ukraine site emphasizes research and development across oncology, vaccines and infectious diseases; sponsorship and conduct of clinical trials (Phases I–IV) in Ukraine; regulatory submissions and pharmacovigilance; business development and licensing; and programs to expand access to medicines including production scale-up and voluntary licensing during public health emergencies.
Industries
N/A
Nr. of Employees
small (1-50)
Products
Vaccines (multiple indications)
Development and global supply of vaccines for prevention of infectious diseases using recombinant and other vaccine technologies.
Therapeutic medicines (oncology, antivirals, cardiometabolic, immunology)
Research, development and supply of small-molecule and biologic therapeutics across oncology, infectious diseases and cardiometabolic indications.
Animal health products
Development and supply of products for animal health and veterinary use.
Vaccines (multiple indications)
Development and global supply of vaccines for prevention of infectious diseases using recombinant and other vaccine technologies.
Therapeutic medicines (oncology, antivirals, cardiometabolic, immunology)
Research, development and supply of small-molecule and biologic therapeutics across oncology, infectious diseases and cardiometabolic indications.
Animal health products
Development and supply of products for animal health and veterinary use.
Services
Sponsorship and management of clinical trials across phases I–IV in multiple therapeutic areas in Ukraine and globally, including local site management and participant monitoring.
Collaboration and licensing for external discoveries across discovery and clinical stages, with a dedicated business development and licensing contact channel for external innovators.
Programmatic partnerships, donations through multilateral channels and voluntary licensing arrangements to increase availability of medicines in low- and middle-income countries.
Advance manufacture and allocation of therapeutic courses, coordination of global supply chains and procurement agreements with governments and multilateral purchasers.
Sponsorship and management of clinical trials across phases I–IV in multiple therapeutic areas in Ukraine and globally, including local site management and participant monitoring.
Collaboration and licensing for external discoveries across discovery and clinical stages, with a dedicated business development and licensing contact channel for external innovators.
Programmatic partnerships, donations through multilateral channels and voluntary licensing arrangements to increase availability of medicines in low- and middle-income countries.
Advance manufacture and allocation of therapeutic courses, coordination of global supply chains and procurement agreements with governments and multilateral purchasers.
Expertise Areas
- Clinical trial management and site operations (Phases I–IV)
- Oncology research and immuno-oncology
- Vaccine research, development and manufacturing
- Infectious disease therapeutics and antiviral development
Key Technologies
- Recombinant vaccine platforms
- Vaccine manufacturing processes and scale-up
- Oral nucleoside-analog antiviral development
- Small-molecule drug development
News & Updates
Announcement of a special permit for emergency use of an investigational oral antiviral in Ukraine and discussion of global supply, advance production, voluntary licensing and procurement agreements to expand access.
Public awareness content describing lung cancer burden, risk factors (including smoking and occupational exposures), symptoms and available diagnostic and treatment approaches.
Educational content about clinical and preclinical research stages and the role of clinical trials in evaluating new treatments prior to approval.
Awareness content on breast cancer epidemiology, risk factors and treatment standards; references local clinical development activity in Ukraine.
Announcement of a special permit for emergency use of an investigational oral antiviral in Ukraine and discussion of global supply, advance production, voluntary licensing and procurement agreements to expand access.
Public awareness content describing lung cancer burden, risk factors (including smoking and occupational exposures), symptoms and available diagnostic and treatment approaches.
Educational content about clinical and preclinical research stages and the role of clinical trials in evaluating new treatments prior to approval.
Awareness content on breast cancer epidemiology, risk factors and treatment standards; references local clinical development activity in Ukraine.